Superovulation in intra uterine insemination: FSH or clomifene citrate?
Recruiting
- Conditions
- unexplained infertility, intra uterine insemination, FSH, clomifene citrate
- Registration Number
- NL-OMON25229
- Lead Sponsor
- Academic Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 732
Inclusion Criteria
At least 12 months of unprotected intercourse without conception.
-At least one sided tubal patency, which is established according to local protocol.
Exclusion Criteria
-Double sided tubal pathology
-Women with irregular cycles, PCOS or other endocrine disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cumulative ongoing pregnancy rate
- Secondary Outcome Measures
Name Time Method 1. Number of cycles with monofollicular growth<br /><br>2. Number of cycles with multiple follicle growth<br /><br>3. Number of cancelled cycles due to the occurrence of >3 follicles >15 mm<br /><br>4. Difference in severity of known adverse effects<br /><br>5. Time to ongoing pregnancy rate<br /><br>6. Clinical pregnancy<br /><br>7. Miscarriage rate<br /><br>8. Live birth rate<br /><br>9. Multiple pregnancies<br /><br>10. Patients preference by DCE<br /><br>11. Direct and indirect costs<br />